Somatic Cell Genome Editing Related Activities

Please note that the funding opportunities below are not issued by the NIH Somatic Cell Genome Editing Program, but are examples of funding opportunities from individual ICs related to somatic cell genome editing . This is not meant to be an exhaustive list; please see the NIH Guide for a complete list of funding opportunity announcements.

Current Funding Opportunities

Title FOA Number
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required) RFA-HL-23-017
Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed) RFA-NS-23-017

New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Respitory Complications of the Muscular Dystrophies (R01) NOT-HL-22-025

This page last reviewed on September 15, 2022